Description
COMPOSITION: Each tablet contains DACLATASAVIR DIHYDOCHOLORIDE 60 mg
INDICATION: DACIKAST is a hepatitis C virus NS5A inhibitor indicated for use with Sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 Infection.
PACKING: 28 Tablets / Bottle